Clinical Trial Update: Erythropoietin Therapy for Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying erythropoietin therapy for aneurysmal subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University of Cambridge | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED